Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer

Nicholas C. Wolff, Dwight E. Randle, Merrill J. Egorin, John D. Minna, Robert L. Ilaria

Research output: Contribution to journalArticle

47 Scopus citations

Fingerprint Dive into the research topics of 'Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences